Article Versions Notes

Sato Y, Motoyama S, Wada Y, Wakita A, Kawakita Y, Nagaki Y, Terata K, Imai K, Anbai A, Hashimoto M, et al. Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis. Cancers. 2021; 13(5):983. https://doi.org/10.3390/cancers13050983

Sato, Yusuke, Satoru Motoyama, Yuki Wada, Akiyuki Wakita, Yuta Kawakita, Yushi Nagaki, Kaori Terata, Kazuhiro Imai, Akira Anbai, Manabu Hashimoto, and et al. 2021. "Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis" Cancers 13, no. 5: 983. https://doi.org/10.3390/cancers13050983

Sato, Y., Motoyama, S., Wada, Y., Wakita, A., Kawakita, Y., Nagaki, Y., Terata, K., Imai, K., Anbai, A., Hashimoto, M., & Minamiya, Y. (2021). Neoadjuvant Chemoradiotherapy Followed by Esophagectomy with Three-Field Lymph Node Dissection for Thoracic Esophageal Squamous Cell Carcinoma Patients with Clinical Stage III and with Supraclavicular Lymph Node Metastasis. Cancers, 13(5), 983. https://doi.org/10.3390/cancers13050983